Gyre Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -39.58M17.95M-8.53M-7.00M-46.70M-32.62M-14.78M-16.95M-21.56M-30.05M-55.14M-56.33M-87.93M3.42M-86.31M16.90M
Depreciation and Depletion 1.98M2.46M2.19M1.00M0.70M0.50M0.40M0.20M0.10M0.90M1.00M1.30M
Share-based Compensation 2.45M4.94M8.51M7.85M0.30M0.24M0.33M0.64M0.86M2.61M3.20M3.63M3.40M13.37M7.28M0.83M
Deferred Taxes -0.84M-1.16M-1.00M
Gains from Sales and Divestitures 0.89M0.80M
Gains from Investment Securities -41.00M-84.48M3.78M4.37M0.25M0.25M0.15M0.14M0.82M1.36M0.16M2.36M2.60M17.04M18.28M18.08M
Asset Writedowns and Impairment 0.05M0.20M
Non-cash Items 624.54M372.29M0.00M1.56M0.11M0.16M0.41M1.34M1.51M4.32M444.20M190.38M
Cash from Operations -24.27M138.30M-83.72M-64.24M-6.27M-6.39M-19.12M-18.47M-19.94M-28.55M-43.61M-55.05M-83.75M10.68M25.89M-3.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.42M0.91M0.94M0.91M0.78M
Amortization of Deferred Charges 1.48M
Depreciation & Amortization (CF) 1.83M2.00M2.48M2.21M0.97M0.68M0.47M0.39M0.17M0.15M0.15M0.14M0.29M1.09M1.07M1.55M
Change in Working Capital
Change in Receivables -0.62M1.16M0.05M-0.00M0.08M-0.46M-0.01M15.00M-11.69M-1.50M-1.62M-0.28M5.26M
Change in Inventory 0.88M-1.75M2.14M
Change in Account Payables 0.01M-0.11M-4.27M-0.10M-0.09M0.50M3.03M1.65M0.50M-0.11M0.42M-0.24M
Change in Accured Expenses 16.55M-3.80M4.42M-11.52M-0.25M-0.00M1.15M-0.06M1.29M0.85M5.60M0.08M-3.68M1.91M1.45M-1.50M
Change in Taxes -1.34M3.00M-2.17M
Other Working Capital Changes 0.47M11.97M5.75M-2.02M2.79M-0.31M0.01M0.01M0.00M0.02M15.00M0.02M0.00M0.05M-0.47M-0.82M
Investing Activities
Capital Expenditures 0.20M3.31M1.43M0.33M0.04M0.00M0.27M0.47M0.02M0.38M0.06M0.84M4.99M8.52M2.31M
Sales of Property, Plant and Equipment 0.04M0.01M1.59M1.17M0.10M1.67M0.50M0.66M0.40M
Change in Intangibles 0.01M0.07M0.81M
Acquisitions 5.59M
Change in Acquisitions & Divestments 41.00M84.48M100.01M159.54M69.88M40.99M13.82M10.00M14.30M127.97M157.43M107.56M49.03M2.50M
Cash from Investing Activities 9.80M-62.80M-57.67M39.82M-0.04M0.10M37.36M-1.31M-11.20M-71.32M27.39M9.66M48.19M-13.81M-19.76M-19.88M
Financing Activities
Other financing activities 0.04M3.50M3.41M3.25M14.33M14.32M0.54M
Cash from Financing Activities 47.18M6.45M82.81M-0.63M5.74M5.01M9.31M0.95M21.08M111.33M0.33M60.38M49.55M-45.01M2.50M2.10M
Dividend Payments
Dividends Paid - Common 45.03M
Additional items
Exchange Rate Effect -1.89M-0.30M-0.27M
Change in Cash 32.71M81.94M-58.57M-25.04M-0.57M-1.28M27.55M-18.83M-10.05M11.46M-15.89M14.99M13.99M-5.03M8.33M-21.70M
Free Cash Flow -24.47M134.99M-85.15M-64.57M-6.32M-6.39M-19.39M-18.94M-19.96M-28.93M-43.68M-55.05M-84.59M5.69M17.38M-5.96M
Net Cash Flow 32.71M81.94M-58.57M-25.04M-0.57M-1.28M27.55M-18.83M-10.05M11.46M-15.89M14.99M13.99M-48.15M8.63M-21.42M